BioSpace News Archive

Biotech Bay

Pulse Biosciences Announces Treatment of First Patients in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation for the Treatment of Sebaceous Hyperplasia Lesions

Multicenter Study Aims to Demonstrate NPS as a Preferred Method for Skin Lesion Removal

July 10, 2018
·
7 min read
Deals

BioCryst Pharmaceuticals Announces Termination of Merger Agreement with Idera Pharmaceuticals

BioCryst Pharmaceuticals, Inc. announced that it has terminated the previously announced merger agreement with Idera Pharmaceuticals, Inc. following the BioCryst stockholders’ failure to approve the adoption of the merger agreement at the BioCryst Special Meeting of Stockholders held today.

July 10, 2018
·
3 min read
Drug Development

SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis

Clinically and mycologically effective and well-tolerated oral dose of SCY-078 identified for use in Phase 3 registration program.

July 10, 2018
·
13 min read
Deals

ArQule Announces Commencement of Proposed Public Offering of Common Stock

ArQule, Inc. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell shares of its common stock.

July 10, 2018
·
4 min read
Business

IQVIA to Announce Second-Quarter 2018 Results on July 24, 2018

IQVIA Holdings Inc. will announce its second-quarter 2018 financial results before the market opens on Tuesday, July 24, 2018.

July 10, 2018
·
2 min read
Business

Illumina to Announce Second Quarter 2018 Financial Results on Monday, July 30, 2018

Illumina, Inc. announced that it will issue results for second quarter 2018 following the close of market on Monday, July 30, 2018.

July 10, 2018
·
1 min read
Policy

McInnis Law: 3 Whistleblower Cases against Health Quest End in Settlements with US and NY for $15.5 Million

McInnis Law announces the resolution of three whistleblower lawsuits against Health Quest Systems, Inc., a hospital system and network of healthcare providers headquartered in Lagrangeville, NY.

July 10, 2018
·
2 min read
Biotech Bay

Antiva Biosciences Closes $15 Million Series C-1 Financing

Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection, has raised $15 million in Series C-1 financing led by Hillhouse Capital Management.

July 10, 2018
·
3 min read
Business

Intel Editorial: How Governments Can Help Advance Artificial Intelligence

Priorities Should Include Education and Research

July 10, 2018
·
5 min read
BioMidwest

Fresenius Kabi Introduces Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL Presentations

Complete portfolio of all commonly used sizes and strengths of Adenosine Injection, USP now available from Fresenius Kabi

July 10, 2018
·
3 min read